title: Asymmetric assessments in valuing pharmaceutical risks.
authors.affiliation: Harvard Law School, Cambridge, MA 02138, USA.
authors.forename: W K
authors.initials: WK
authors.lastname: Viscusi
authors.forename: W A
authors.initials: WA
authors.lastname: Magat
authors.forename: R
authors.initials: R
authors.lastname: Scharff
mesh_terms: D017277:Drug Approval / Q000331:legislation & jurisprudence*; D064420:Drug-Related Side Effects and Adverse Reactions; D017850:Economics, Pharmaceutical; D006801:Humans; D018570:Risk Assessment; D006113:United Kingdom; D014481:United States; D014486:United States Food and Drug Administration